Evaluation of the Impact of a Patient Education Protocol on the Quality of 18F-FDG PET Imaging Indicated for Investigation of Cardiac Inflammation
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jun 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether giving patients clear instructions and education before a special heart scan called an 18F-FDG PET can improve the quality of the images. This scan helps doctors find inflammation (swelling or irritation) in the heart caused by conditions like infective endocarditis or cardiac sarcoidosis. For the scan to work well, patients need to prepare by following a specific diet so their heart muscle doesn’t absorb sugar from food, which can make the images harder to read. The study wants to see if better patient preparation can help doctors get clearer results, which could lead to faster and more accurate diagnoses.
Adults aged 18 and older who have been prescribed this heart scan and understand French may be eligible to join, as long as they are not pregnant, already on a special diet, or unable to follow the study’s instructions. Participants will be asked to follow the education and preparation plan before their scan, and the researchers will compare the quality of their images to those who did not receive this extra guidance. The study will take place at two hospitals in Paris and aims to include 138 people. If you’re considering taking part, you should know that giving your consent and having an email address are required, and the study focuses on helping improve the scan process for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presence of a prescription validated by the nuclear medicine department for an 18F-FDG PET scan for the detection of inflammation of cardiac inflammation or infection
- • Age greater than or equal to 18
- • Membership of a social security scheme or equivalent
- • Patients with an e-mail address
- • Patients who understand French
- • Collection of patient consent
- Exclusion Criteria:
- • Pregnancy or breast-feeding
- • Patients (inpatients or outpatients) already on a diet (including ketogenic)
- • Patients who do not understand protocol
- • Patients deprived of liberty by judicial or administrative decision
- • Patients under legal protection (guardianship/trusteeship)
- • Patients under court protection
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Paris, , France
Patients applied
Trial Officials
Julien HO
Principal Investigator
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported